Vident Advisory, LLC

SEC CIK: 0001744347
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

AMLX holding history

Amylyx Pharmaceuticals, Inc. in every 13F filed by Vident Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMLX overview All 13F holders of AMLX Full Q2 2026 holdings

Shares (Q1 2025): 0; Sold out in Q1 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2024

Holdings of AMLX by Vident Advisory, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2025	0	$0	0.0%	−10,862−100.0%	Sold out	Holders
Q4 2024	10,862	$41.1K	<0.1%	−4,710−30.2%	Reduced	Holders
Q3 2024	15,572	$50.5K	<0.1%	+4,729+43.6%	Added	Holders
Q2 2024	10,843	$20.6K	<0.1%	+10,843	New	Holders